Amgen (AMGN) Business News

Track Amgen in real time with a live news feed covering Amgen stock news, official press releases, company announcements, and an archive of historical Amgen news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
10:01 AM | Monday | Jul 13, 2026 Zacks Investment Research

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

NEW News Thumbnail
7:30 AM | Monday | Jul 13, 2026 GuruFocus

AMGN DCF Analysis: Intrinsic Value $292 vs Price $363

NEW News Thumbnail
11:35 AM | Thursday | Jul 9, 2026 24/7 Wall Street

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

News Thumbnail
11:35 AM | Thursday | Jul 9, 2026 24/7 Wall Street

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

News Thumbnail
12:30 PM | Tuesday | Jul 7, 2026 24/7 Wall Street

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

News Thumbnail
7:01 PM | Monday | Jul 6, 2026 Zacks Investment Research

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

News Thumbnail
2:29 PM | Monday | Jul 6, 2026 Fool - Investing News

The Dow Couldn't Keep Up With Chip Stocks on Monday

News Thumbnail
1:01 PM | Monday | Jul 6, 2026 Zacks Investment Research

Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?

News Thumbnail
10:05 AM | Wednesday | Jul 1, 2026 Zacks Investment Research

Amgen or Biogen: Which Biotech Stock Appears Better Poised?

News Thumbnail
9:16 AM | Wednesday | Jul 1, 2026 Zacks Investment Research

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

News Thumbnail
10:01 AM | Tuesday | Jun 30, 2026 Zacks Investment Research

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

News Thumbnail
6:05 AM | Tuesday | Jun 30, 2026 The Motley Fool

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

News Thumbnail
9:24 AM | Monday | Jun 29, 2026 Benzinga

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

News Thumbnail

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

10:01 AM | Monday | Jul 13, 2026

news photo
Loading...

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read full article redirect
10:01 AM | Monday | Jul 13, 2026

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Read full article arrow
NEW News Thumbnail
7:30 AM | Monday | Jul 13, 2026

AMGN DCF Analysis: Intrinsic Value $292 vs Price $363

GuruFocus

On July 13, 2026, we present a detailed DCF analysis for Amgen Inc (AMGN), a company that has shown significant price performance over the past year with a 24.6

Read full article arrow
NEW News Thumbnail
11:35 AM | Thursday | Jul 9, 2026

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

24/7 Wall Street

CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.

Read full article arrow
News Thumbnail
11:35 AM | Thursday | Jul 9, 2026

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

24/7 Wall Street

CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.

Read full article arrow
News Thumbnail
12:30 PM | Tuesday | Jul 7, 2026

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

24/7 Wall Street

On CNBC's Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing that the sector could be entering a new wave of mergers and acquisitions as the regulatory environment becomes more favorable for dealmaking.

Read full article arrow
News Thumbnail
7:01 PM | Monday | Jul 6, 2026

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Zacks Investment Research

Amgen (AMGN) closed the most recent trading day at $366.44, moving 2.06% from the previous trading session.

Read full article arrow
News Thumbnail
2:29 PM | Monday | Jul 6, 2026

The Dow Couldn't Keep Up With Chip Stocks on Monday

Fool - Investing News

Broadcom's Apple deal and AMD's self-driving ambitions powered the Nasdaq higher on Monday while the Dow spun its wheels.

Read full article arrow
News Thumbnail
1:01 PM | Monday | Jul 6, 2026

Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research

Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read full article arrow
News Thumbnail
10:05 AM | Wednesday | Jul 1, 2026

Amgen or Biogen: Which Biotech Stock Appears Better Poised?

Zacks Investment Research

AMGN stands out compared to Biogen given its broader product portfolio, pipeline depth and steadier growth outlook despite patent and competition risks.

Read full article arrow
News Thumbnail
9:16 AM | Wednesday | Jul 1, 2026

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Zacks Investment Research

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

Read full article arrow
News Thumbnail
10:01 AM | Tuesday | Jun 30, 2026

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks Investment Research

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
6:05 AM | Tuesday | Jun 30, 2026

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

The Motley Fool

Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter.

Read full article arrow
News Thumbnail
9:24 AM | Monday | Jun 29, 2026

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

Benzinga

The U.S. Food and Drug Administration on Friday approved Viridian Therapeutics Inc.'s (NASDAQ:VRDN) new thyroid eye disease (TED) treatment, Lumvoa (veligrotug-vvze).

Read full article arrow
News Thumbnail